These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34216789)

  • 1. Microbial dysbiosis and epigenetics modulation in cancer development - A chemopreventive approach.
    Haque S; Raina R; Afroze N; Hussain A; Alsulimani A; Singh V; Mishra BN; Kaul S; Kharwar RN
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):666-681. PubMed ID: 34216789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy.
    Khan FH; Bhat BA; Sheikh BA; Tariq L; Padmanabhan R; Verma JP; Shukla AC; Dowlati A; Abbas A
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):732-742. PubMed ID: 34273520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenome - A mediator for host-microbiome crosstalk.
    Peery RC; Pammi M; Claud E; Shen L
    Semin Perinatol; 2021 Oct; 45(6):151455. PubMed ID: 34246487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
    Chen B; Sun L; Zhang X
    J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Diet-Gut Microbiota-Epigenetics Crosstalk Relevant to Neonatal Diabetes.
    Alsharairi NA
    Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer.
    Parida S; Sharma D
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):392-405. PubMed ID: 30981803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota and epigenetics: Health impact.
    Ahrodia T; Kandiyal B; Das B
    Prog Mol Biol Transl Sci; 2023; 198():93-117. PubMed ID: 37225326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
    Fan X; Jin Y; Chen G; Ma X; Zhang L
    Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome Dysbiosis and Predominant Bacterial Species as Human Cancer Biomarkers.
    Shirazi MSR; Al-Alo KZK; Al-Yasiri MH; Lateef ZM; Ghasemian A
    J Gastrointest Cancer; 2020 Sep; 51(3):725-728. PubMed ID: 31605288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of alcohol induced gut dysbiosis and the resulting behavioral impact.
    Qamar N; Castano D; Patt C; Chu T; Cottrell J; Chang SL
    Behav Brain Res; 2019 Dec; 376():112196. PubMed ID: 31476330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses.
    Jaye K; Li CG; Bhuyan DJ
    Crit Rev Oncol Hematol; 2021 Sep; 165():103429. PubMed ID: 34293459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between the lung microbiome and lung cancer.
    Mao Q; Jiang F; Yin R; Wang J; Xia W; Dong G; Ma W; Yang Y; Xu L; Hu J
    Cancer Lett; 2018 Feb; 415():40-48. PubMed ID: 29197615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
    Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
    Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of gut microbiota in the development of colorectal cancer: a review.
    Koyande N; Gangopadhyay M; Thatikonda S; Rengan AK
    Int J Colorectal Dis; 2022 Jul; 37(7):1509-1523. PubMed ID: 35704091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the microbiome with colorectal cancer development (Review).
    Abdulla MH; Agarwal D; Singh JK; Traiki TB; Pandey MK; Ahmad R; Srivastava SK
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.
    Farhana L; Banerjee HN; Verma M; Majumdar APN
    Methods Mol Biol; 2018; 1856():35-55. PubMed ID: 30178245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
    Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
    Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.